SciELO - Scientific Electronic Library Online

 
vol.9 issue3Atypical presentation urinary infection: Clinical case and literature reviewKaposi sarcoma in oropharynx in renal postrasplantation patient management with co-stimulation signal inhibitor and mTOR inhibitor author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Nefrología

On-line version ISSN 2500-5006

Abstract

VARGAS, Diana; CASTILLO ARTEAGA, Mariangel  and  SANCHEZ-TORDECILLA, María. Hepatopancreatic manifestations in atypical hemolytic uremic syndrome. Rev. colom. nefrol. [online]. 2022, vol.9, n.3, 404.  Epub Jan 01, 2023. ISSN 2500-5006.  https://doi.org/10.22265/acnef.9.3.595.

Introduction:

Atypical hemolytic uremic syndrome is a severe and orphan disease, in its atypical variety courses with extrarenal clinical manifestations. The presence of gastrointestinal compromise is infrequent, but the prognosis is unfavorable, since they have more relapses and higher mortality. Therefore, it is important that physicians are trained in recognizing the rare manifestations of this pathology, in order to improve the outcome in these patients.

Purpose:

This case illustrates a unique case in terms of symptoms and etiology not previously described.

Case presentation:

We report the case of an 8-year-old male who presented with fever, jaundice, abdominal and lumbar pain, diarrhea, hematemesis, and hematuria. Atypical hemolytic uremic syndrome was diagnosed. He presented clinical deterioration with multiple organ involvement, documenting high blood pressure and acute kidney injury, who received management with crystalloids and diuretics without improvement, requiring renal replacement therapy and multiple transfusional support. However, there was still no clinical improvement, so the start of recombinant humanized IgG monoclonal antibody was indicated, with satisfactory outcomes.

Discussion and conclusions:

This case is a clear example that extrarenal and multi-organ involvement can be the main manifestation of this disease, so it is important that clinicians are aware of the clinical course that may develop a patient with atypical presentations, in order to avoid diagnostic and therapeutic delays. Likewise, the etiological approach is important in order to provide an accurate prognosis to the patient and his family.

Keywords : atypical hemolytic uremic syndrome; hepatitis; pancreatitis; eculizumab; mutation..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )